Fund & Portfolio Comparison

Performance Comparison
Comparison Box

Portfolio Performance Comparison
Name YTD Return 1Yr AR 3Yr AR 5Yr AR 10Yr AR 15Yr AR 20Yr AR Common Inception
RNAZ (TransCode Therapeutics, Inc.) NA -99.90% -98.96% NA NA NA NA
Data as of 11/28/2025, Common starting date is 07/09/2021
More Performance Analytics Comparison
Name Start Date End Date
RNAZ (TransCode Therapeutics, Inc.) 07/09/2021 11/28/2025
Last 1 Week 1 Yr 3 Yr 5 Yr 10 Yr 15 Yr 20 Yr Common Inception 2025 2024 2023 2022 2021
Annualized Return (%) 7.52 -99.90 -98.96 NA NA NA NA -99.64 -98.50 -98.73 -73.62 -51.98
Sharpe Ratio NA -0.26 -0.34 NA NA NA NA -0.25 -0.48 -0.45 -0.51 -0.69
Standard Deviation(%) NA 397.45 298.31 NA NA NA NA 411.76 220.23 228.17 146.09 113.50
Draw Down(%) NA 99.93 100.00 NA NA NA NA 99.93 98.50 99.18 89.11 63.26
Yield(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Data as of 11/28/2025, Common starting date is 07/09/2021
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
RNAZ (TransCode Therapeutics, Inc.) -99.44%
May 2022 – May 2025
0.00%
NA
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison (Maximum)
Ticker/Portfolio Name 3 Year 5 Year 10 Year 15 Year
RNAZ (TransCode Therapeutics, Inc.) -93.80%
Sep 2021 – Sep 2024
0.00%
NA
0.00%
NA
0.00%
NA
Annualized Rolling Returns Comparison Chart

3-Year Annualized Rolling Return